Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to do so could be grounds for compensation. Our lawyers are operating challenging to have those hurt by the drug the compensation they may be entitled to.
Even though bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is a lot more harmful than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, individuals might be at threat for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.
In the event you or possibly a loved 1 suffered a severe bleeding occasion after taking Xarelto, you might have legal recourse. For far more information, make contact with us nowadays to have your case reviewed, free of charge.Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related
bills, lost wages, pain and suffering and, in circumstances of death, funeral costs. In addition, they may be seeking punitive damages, that are generally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, xareltoattorneys.bitbucket.org
from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.